{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:59:53Z","timestamp":1790283593813,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001849","name":"Defence Research and Development Organisation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001849","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Journal Armed Forces India"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.mjafi.2025.11.016","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T12:33:33Z","timestamp":1768221213000},"page":"549-555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Study of non-alcoholic fatty liver disease in human immunodeficiency virus patients by controlled attenuation parameter"],"prefix":"10.1016","volume":"82","author":[{"given":"Manish","family":"Manrai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3503-3737","authenticated-orcid":false,"given":"Yogendra","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Dawra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pittadaa","family":"Dwarkanadh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mangesh","family":"Kritya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"36","key":"10.1016\/j.mjafi.2025.11.016_bib1","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.3748\/wjg.v23.i36.6571","article-title":"Nonalcoholic fatty liver disease: evolving paradigms","volume":"23","author":"Lonardo","year":"2017","journal-title":"WJG"},{"issue":"5","key":"10.1016\/j.mjafi.2025.11.016_bib2","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/QAI.0b013e318198a88a","article-title":"Nonalcoholic fatty liver disease among HIV-infected persons","volume":"50","author":"Crum-Cianflone","year":"2009","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1016\/j.mjafi.2025.11.016_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clinre.2011.08.001","article-title":"The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using fibroscan\u00ae","volume":"36","author":"Sasso","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"issue":"7","key":"10.1016\/j.mjafi.2025.11.016_bib4","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/jgh.12557","article-title":"Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease: controlled attenuation parameter","volume":"29","author":"Chan","year":"2014","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.mjafi.2025.11.016_bib5","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s12072-020-10094-2","article-title":"The Asian Pacific association for the study of the liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease","volume":"14","author":"Eslam","year":"2020","journal-title":"Hepatol Int"},{"issue":"16","key":"10.1016\/j.mjafi.2025.11.016_bib6","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.2169\/internalmedicine.50.4682","article-title":"Serum dehydroepiandrosterone sulphate levels in patients with non-alcoholic fatty liver disease","volume":"50","author":"Koga","year":"2011","journal-title":"Intern Med"},{"issue":"3","key":"10.1016\/j.mjafi.2025.11.016_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/XCE.0000000000000057","article-title":"Relevance of low testosterone to nonalcoholic fatty liver disease","volume":"4","author":"Mody","year":"2015","journal-title":"Cardiovasc Endocrinol"},{"issue":"11","key":"10.1016\/j.mjafi.2025.11.016_bib8","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/QAD.0000000000001504","article-title":"Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-Monoinfection","volume":"31","author":"Maurice","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.mjafi.2025.11.016_bib9","series-title":"Standard treatment guidelines: hypertension: screening, diagnosis, assessment, and management of primary hypertension in adults in India","year":"2016"},{"key":"10.1016\/j.mjafi.2025.11.016_bib10","series-title":"Standard treatment guidelines: diabetes mellitus: screening, diagnosis, assessment, and management of diabetes mellitus in adults in India","year":"2018"},{"issue":"5","key":"10.1016\/j.mjafi.2025.11.016_bib11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ajg.2016.49","article-title":"The performance of vibration controlled transient elastography in a US cohort of patients with nonalcoholic fatty liver disease","volume":"111","author":"Tapper","year":"2016","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.mjafi.2025.11.016_bib12","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","article-title":"Controlled attenuation parameter (CAP): a novel VCTETM guided ultrasonic attenuation measurement for the evaluation of hepatic steatosis: Preliminary study and validation in a cohort of patients with chronic liver disease from various causes","volume":"36","author":"Sasso","year":"2010","journal-title":"Ultrasound Med Biol"},{"issue":"2","key":"10.1016\/j.mjafi.2025.11.016_bib13","first-page":"75","article-title":"Fatty liver disease in persons with HIV infection","volume":"27","author":"Seth","year":"2019","journal-title":"Top Antivir Med"},{"issue":"7","key":"10.1016\/j.mjafi.2025.11.016_bib14","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.cgh.2023.01.001","article-title":"Prevalence and characteristics of nonalcoholic fatty liver disease and fibrosis in people living with HIV monoinfection: a systematic review and meta-analysis","volume":"21","author":"Kalligeros","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.mjafi.2025.11.016_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26072","article-title":"Uncovering the NAFLD burden in people living with HIV from high- and middle-income nations: a meta-analysis with a data gap from subsaharan Africa","volume":"26","author":"Manzano-Nunez","year":"2023","journal-title":"J Int AIDS Soc"},{"issue":"17","key":"10.1016\/j.mjafi.2025.11.016_bib16","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1097\/QAD.0000000000001241","article-title":"Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients","volume":"30","author":"Vuille-Lessard","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.mjafi.2025.11.016_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101116","article-title":"Stratifying the risk of NAFLD in patients with HIV under combination antiretroviral therapy (cART)","volume":"40","author":"Bischoff","year":"2021","journal-title":"eClinicalMedicine"},{"issue":"2","key":"10.1016\/j.mjafi.2025.11.016_bib18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5005\/jp-journals-10018-1189","article-title":"Nonalcoholic fatty liver disease in south Asia","volume":"6","author":"Pati","year":"2016","journal-title":"Euroasian J Hepatogastroenterol"},{"issue":"1","key":"10.1016\/j.mjafi.2025.11.016_bib19","first-page":"76","article-title":"Non-alcoholic fatty liver disease in South Asians: a review of the literature","volume":"5","author":"Singh","year":"2017","journal-title":"J Clin Transl Hepatol"},{"issue":"12","key":"10.1016\/j.mjafi.2025.11.016_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2022.102679","article-title":"Indian patients with human immunodeficiency virus infection have high prevalence but mild severity of non-alcoholic fatty liver disease","volume":"16","author":"De","year":"2022","journal-title":"Diabetes Metabol Syndr: Clin Res Rev"},{"issue":"5","key":"10.1016\/j.mjafi.2025.11.016_bib21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2036.2010.04556.x","article-title":"Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: systematic review: diagnosis and staging of NAFLD","volume":"33","author":"Dowman","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.mjafi.2025.11.016_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-230X-12-27","article-title":"Assessment of liver fibrosis and associated risk factors in HIV-Infected individuals using transient elastography and serum biomarkers","volume":"12","author":"Vermehren","year":"2012","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"10.1016\/j.mjafi.2025.11.016_bib23","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/589294","article-title":"Nonalcoholic fatty liver disease in HIV-Infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors","volume":"47","author":"Guaraldi","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.mjafi.2025.11.016_bib24","doi-asserted-by":"crossref","first-page":"e571","DOI":"10.1093\/cid\/ciac708","article-title":"Liver inflammation is common and linked to metabolic derangements in persons with treated human immunodeficiency virus (HIV)","volume":"76","author":"Chew","year":"2023","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.mjafi.2025.11.016_bib25","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/apt.13052","article-title":"Clinical, biochemical and histological differences between HIV -associated NAFLD and primary NAFLD : a case\u2013control study","volume":"41","author":"Vodkin","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"10.1016\/j.mjafi.2025.11.016_bib26","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S1473-3099(13)70271-8","article-title":"Metabolic disease in HIV infection","volume":"13","author":"Lake","year":"2013","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"10.1016\/j.mjafi.2025.11.016_bib27","first-page":"1325","article-title":"Non-alcoholic fatty liver disease in patients with HIV infection","volume":"20","author":"Papagianni","year":"2018","journal-title":"AIDS Rev"},{"issue":"1","key":"10.1016\/j.mjafi.2025.11.016_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087596","article-title":"Traditional but not HIV-related factors are associated with nonalcoholic fatty liver disease in Asian patients with HIV-1 infection","volume":"9","author":"Nishijima","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.mjafi.2025.11.016_bib29","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/hep.22063","article-title":"Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease","volume":"47","author":"Charlton","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mjafi.2025.11.016_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3803\/EnM.2019.34.2.95","article-title":"Human immunodeficiency virus infection and the endocrine system","volume":"34","author":"Zaid","year":"2019","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"1","key":"10.1016\/j.mjafi.2025.11.016_bib31","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4103\/2230-8210.146870","article-title":"Endocrine alterations in HIV-infected patients","volume":"19","author":"Tripathy","year":"2015","journal-title":"Indian J Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.mjafi.2025.11.016_bib32","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology"}],"container-title":["Medical Journal Armed Forces India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123725003429?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0377123725003429?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:08:47Z","timestamp":1790280527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0377123725003429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0377123725003429"],"URL":"https:\/\/doi.org\/10.1016\/j.mjafi.2025.11.016","relation":{},"ISSN":["0377-1237"],"issn-type":[{"value":"0377-1237","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study of non-alcoholic fatty liver disease in human immunodeficiency virus patients by controlled attenuation parameter","name":"articletitle","label":"Article Title"},{"value":"Medical Journal Armed Forces India","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mjafi.2025.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd.","name":"copyright","label":"Copyright"}]}}